| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.0037 | 1 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Dasatinib | FIMM | pan-cancer | AAC | 0.011 | 1 |
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.0026 | 1 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |